SD 0006 is an Orally Active MAPK p38α Inhibitor for the Treatment of Rheumatoid Arthritis
In previous blogs, we have introduced a few MAPK p38 inhibitors. As a result, MAPK p38 plays an important role in many diseases, including cancer and inflammatory diseases. Today, I’d…